Lakefront Biotherapeutics (LKFT) had the highest return in 2015 by a small-cap US stock, returning 231.7%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Lakefront Biotherapeutics (LKFT) | 2015 | 231.72% |
Prothena (PRTA) | 2015 | 224.33% |
LightPath Technologies (LPTH) | 2015 | 210.99% |
eXp World (AGNT) | 2015 | 184.72% |
Sarepta Therapeutics (SRPT) | 2015 | 164.61% |
Ultragenyx (RARE) | 2015 | 152.54% |
Globant (GLOB) | 2015 | 142.78% |
LeMaitre Vascular (LMAT) | 2015 | 137.18% |
Smith & Wesson Brands (SWBI) | 2015 | 130.16% |
Collegium Pharmaceutical (COLL) | 2015 | 129.17% |
Aclaris Therapeutics (ACRS) | 2015 | 125.63% |
Iradimed (IRMD) | 2015 | 118.99% |
Frp Holdings Ord (FRPH) | 2015 | 106.46% |
Lexicon Pharmaceuticals (LXRX) | 2015 | 104.45% |
DiaMedica Therapeutics (DMAC) | 2015 | 90% |
Volaris (VLRS) | 2015 | 89.2% |
Empresa Distribuidora y Comercializadora Norte SA ADR (EDN) | 2015 | 85.11% |
Lendingtree (TREE) | 2015 | 84.08% |
Genie Energy (GNE) | 2015 | 83.63% |
LSI Industries (LYTS) | 2015 | 81.59% |
Neurogene (NGNE) | 2015 | 75.01% |
Sturm Ruger (RGR) | 2015 | 74.29% |
Integra LifeSciences (IART) | 2015 | 74.15% |
Nordic American Tankers (NAT) | 2015 | 70.54% |
Zevra Therapeutics (ZVRA) | 2015 | 69.02% |
Small-cap stocks are treated as having a market cap between $300M and $2B.